Aims: There is a high frequency of serous gynaecological and basal breast cancers in patients with germline BRCA1 mutations. These patients often undergo prophylactic salpingo-oophorectomies, where small tumours may be identified in which morphological distinction between primary serous and metastatic basal breast cancer may be problematic. These two cancer types share similar molecular genetics and have immunophenotypic overlap. We aimed to develop an immunohistochemical panel which could differentiate between these two tumour types
Purpose: Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that...
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ...
Background: Grade-III invasive ductal carcinomas of no special type (IDCs-NST) constitute a heteroge...
"Basal'' breast cancers are dominating the breast research literature at present and pathologists ar...
Aims: Recently, an immunohistochemical panel comprising antibodies against HER2, oestrogen receptor ...
Histological special types (HST) account for about 25% of breast cancers, and correspond to at least...
Ovarian carcinomas are heterogenous group of diseases comprising various histotypes. Ovarian carcino...
AimsMany immunohistochemical markers have been studied for differentiating papillary lesions. Howeve...
Aims: Ductal carcinoma in situ (DCIS) is an established late precursor of sporadic invasive breast c...
Introduction: Breast carcinomas are heterogeneous disease with different prognosis and therapy respo...
Tubo-ovarian transitional cell carcinoma (TCC) is grouped with high-grade serous carcinoma (HGSC) in...
To improve our understanding of the biological relationships among different types of cancer, we hav...
Objectives: The aim of this study was to use immunohistochemistry to differentiate solid papillary c...
Purpose : The morphologic and molecular phenotype of breast cancers may help identify patients who a...
PURPOSE: The morphologic and molecular phenotype of breast cancers may help identify patients who ar...
Purpose: Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that...
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ...
Background: Grade-III invasive ductal carcinomas of no special type (IDCs-NST) constitute a heteroge...
"Basal'' breast cancers are dominating the breast research literature at present and pathologists ar...
Aims: Recently, an immunohistochemical panel comprising antibodies against HER2, oestrogen receptor ...
Histological special types (HST) account for about 25% of breast cancers, and correspond to at least...
Ovarian carcinomas are heterogenous group of diseases comprising various histotypes. Ovarian carcino...
AimsMany immunohistochemical markers have been studied for differentiating papillary lesions. Howeve...
Aims: Ductal carcinoma in situ (DCIS) is an established late precursor of sporadic invasive breast c...
Introduction: Breast carcinomas are heterogeneous disease with different prognosis and therapy respo...
Tubo-ovarian transitional cell carcinoma (TCC) is grouped with high-grade serous carcinoma (HGSC) in...
To improve our understanding of the biological relationships among different types of cancer, we hav...
Objectives: The aim of this study was to use immunohistochemistry to differentiate solid papillary c...
Purpose : The morphologic and molecular phenotype of breast cancers may help identify patients who a...
PURPOSE: The morphologic and molecular phenotype of breast cancers may help identify patients who ar...
Purpose: Breast carcinomas expressing basal epithelium cytokeratins constitute a tumor subgroup that...
OBJECTIVE: To determine the frequency of the immunohistochemical profiles of a series of high-grade ...
Background: Grade-III invasive ductal carcinomas of no special type (IDCs-NST) constitute a heteroge...